Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7160813> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q7160813 subject Q7211328.
- Q7160813 subject Q8825202.
- Q7160813 abstract "Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of Template:MONTHNAME 2010[[Category:Articles containing potentially dated statements from Template:MONTHNAME 2010]], Phase II clinical trials have been completed. It is being developed by Amgen.Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.".
- Q7160813 atcPrefix "none".
- Q7160813 casNumber "330988-75-5".
- Q7160813 fdaUniiCode "Q5I7SFZ853".
- Q7160813 wikiPageWikiLink Q12140.
- Q7160813 wikiPageWikiLink Q187255.
- Q7160813 wikiPageWikiLink Q2035485.
- Q7160813 wikiPageWikiLink Q30612.
- Q7160813 wikiPageWikiLink Q415343.
- Q7160813 wikiPageWikiLink Q470517.
- Q7160813 wikiPageWikiLink Q5009777.
- Q7160813 wikiPageWikiLink Q682252.
- Q7160813 wikiPageWikiLink Q7211328.
- Q7160813 wikiPageWikiLink Q8825202.
- Q7160813 atcPrefix "none".
- Q7160813 casNumber "330988".
- Q7160813 unii "Q5I7SFZ853".
- Q7160813 type ChemicalSubstance.
- Q7160813 type Drug.
- Q7160813 type ChemicalObject.
- Q7160813 type Thing.
- Q7160813 type Q8386.
- Q7160813 comment "Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of Template:MONTHNAME 2010[[Category:Articles containing potentially dated statements from Template:MONTHNAME 2010]], Phase II clinical trials have been completed. It is being developed by Amgen.Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.".
- Q7160813 label "Pegsunercept".